Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study
Lee E, Walker C, Ayadi B (2024). Altern Ther Health Med.
Summary
An open-label pilot study in 12 women with interstitial cystitis who had not responded to conventional therapy. Ten of 12 reported complete resolution of symptoms after one treatment and rated it a complete success; the other two rated success at 80%. No adverse events were reported. The authors note the small sample and the absence of a control group. No funding or conflicts were declared.